Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3
Clinical trial NCT00056862 · COMPLETED
Trial details
- NCT number
- NCT00056862
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Primary completion
- 2010-01-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.